| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net income (loss) | 1,319 | 830 | 405 | 83 |
| Provision for credit losses | 363 | 256 | 118 | 296 |
| Depreciation, amortization, and accretion, net | 18 | 11 | 3 | 68 |
| Increase in cash surrender value of corporate-owned life insurance | 90 | 59 | 29 | 86 |
| Stock-based compensation expense | 99 | 63 | 30 | 76 |
| Deferred income taxes (benefit) | 15 | -16 | -30 | 138 |
| Proceeds from sales of loans held for sale | 6,756 | 3,767 | 1,725 | 5,099 |
| Originations of loans held for sale, net of repayments | 6,935 | 3,506 | 1,702 | 5,711 |
| Net losses (gains) on sales of loans held for sale | 93 | 60 | 30 | 84 |
| Net losses (gains) on leased equipment | 0 | 0 | -4 | 8 |
| Net securities and other investments losses (gains) | -6 | 0 | 0 | -948 |
| Net losses (gains) on sales of fixed assets | 0 | 0 | - | 4 |
| Trading account assets | -311 | 91 | 13 | 262 |
| Accrued income and other assets | 77 | -95 | 189 | -224 |
| Accrued expense and other liabilities | -694 | -733 | -792 | -780 |
| Other operating activities, net | -522 | -505 | -300 | 784 |
| Net cash provided by (used in) operating activities | 1,490 | 1,094 | -140 | -1,063 |
| Net decrease (increase) in other investments | - | 16 | 7 | - |
| Net decrease (increase) in short-term investments, excluding acquisitions | -4,170 | -5,940 | -2,155 | 11,979 |
| Purchases of securities available for sale | 6,517 | 5,419 | 3,970 | 12,562 |
| Proceeds from sales of securities available for sale | 5 | 0 | 0 | 15,898 |
| Proceeds from prepayments and maturities of securities available for sale | 4,976 | 3,256 | 1,509 | 1,758 |
| Proceeds from prepayments and maturities of held-to-maturity securities | 759 | 484 | 236 | 881 |
| Purchases of held-to-maturity securities | 868 | - | - | 0 |
| Net decrease (increase) in other investments | 120 | - | - | -130 |
| Net decrease (increase) in loans, excluding acquisitions, sales and transfers | 1,950 | 2,294 | 679 | -6,962 |
| Proceeds from sales of portfolio loans | 122 | 66 | 36 | 156 |
| Proceeds from corporate-owned life insurance | 56 | 30 | 19 | 90 |
| Purchases of premises, equipment, and software | 62 | 33 | 10 | 42 |
| Proceeds from sales of premises and equipment | 3 | 3 | 0 | 12 |
| Net cash provided by (used in) investing activities | 814 | 2,017 | -711 | 1,304 |
| Net increase (decrease) in deposits | 1,005 | -2,855 | 977 | 4,766 |
| Net increase (decrease) in short-term borrowings | -795 | 630 | 206 | -688 |
| Net proceeds from issuance of long-term debt | 1,484 | 1,411 | 833 | 1,565 |
| Payments on long-term debt | 2,981 | 1,714 | 701 | 5,649 |
| Employee equity compensation program common share repurchases | 35 | 35 | 35 | 27 |
| Net proceeds from reissuance of common shares | 5 | 3 | 2 | 5 |
| Repurchases of long-term debt | - | - | - | 0 |
| Net proceeds from scotiabank investment | 0 | - | - | 811 |
| Open market common share repurchases | - | - | - | 0 |
| Cash dividends paid | 792 | 528 | 265 | 689 |
| Net cash provided by (used in) financing activities | -2,109 | -3,088 | 1,017 | 94 |
| Net increase (decrease) in cash and due from banks | 195 | 23 | 166 | 335 |
| Cash and cash equivalents at beginning of period | 1,743 | - | - | - |
| Cash and cash equivalents at end of period | 1,938 | - | - | - |
KEYCORP NEW (KEY)
KEYCORP NEW (KEY)